Post-earnings recap
Reported
Tue, May 8, 2012
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
25%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Arrowhead Pharmaceuticals reported a loss per share of $0.50, with no revenue figures available. The stock reacted slightly down by 0.23%, indicating a muted response from investors, likely due to the lack of detailed financial metrics and management commentary.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.50 | N/A | — |
| Revenue | N/A | N/A | — |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.